UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Sie befinden Sich nicht im Netzwerk der Universität Paderborn. Der Zugriff auf elektronische Ressourcen ist gegebenenfalls nur via VPN oder Shibboleth (DFN-AAI) möglich. mehr Informationen...

Clinical and Pathological Characteristics of KEAP1 - and NFE2L2 -Mutated Non-Small Cell Lung Carcinoma (NSCLC)

Clinical cancer research, 2018-07, Vol.24 (13), p.3087-3096

2018

Link zum Volltext

Verfügbarkeit prüfen

NOTCH, ASCL1, p53 and RB alterations define an alternative pathway driving neuroendocrine and small cell lung carcinomas

International journal of cancer, 2016-02, Vol.138 (4), p.927-938

2016

Link zum Volltext

Verfügbarkeit prüfen

Testing NTRK testing: Wet‐lab and in silico comparison of RNA‐based targeted sequencing assays

Genes chromosomes & cancer, 2020-03, Vol.59 (3), p.178-188

2020

Link zum Volltext

Verfügbarkeit prüfen

Predictive molecular pathology of lung cancer in Germany with focus on gene fusion testing: Methods and quality assurance

Cancer cytopathology, 2020-09, Vol.128 (9), p.611-621

2020

Link zum Volltext

Verfügbarkeit prüfen

Analysis of tumor mutational burden: correlation of five large gene panels with whole exome sequencing

Scientific reports, 2020-07, Vol.10 (1), p.11387-11387, Article 11387

2020

Link zum Volltext

Verfügbarkeit prüfen

Genetic instability and recurrent MYC amplification in ALK‐translocated NSCLC: a central role of TP53 mutations

The Journal of pathology, 2018-09, Vol.246 (1), p.67-76

2018

Link zum Volltext

Verfügbarkeit prüfen

Managing Difficulties of Microsatellite Instability Testing in Endometrial Cancer-Limitations and Advantages of Four Different PCR-Based Approaches

Cancers, 2021-03, Vol.13 (6), p.1268

2021

Link zum Volltext

Verfügbarkeit prüfen

Prevalence and potential biological role of TERT amplifications in ALK translocated adenocarcinoma of the lung

Histopathology, 2021-03, Vol.78 (4), p.578-585

2021

Link zum Volltext

Verfügbarkeit prüfen

NGS-based BRCA1/2 mutation testing of high-grade serous ovarian cancer tissue: results and conclusions of the first international round robin trial

Virchows Archiv : an international journal of pathology, 2016-06, Vol.468 (6), p.697-705

2016

Link zum Volltext

Verfügbarkeit prüfen

Comparative proteomics reveals a diagnostic signature for pulmonary head‐and‐neck cancer metastasis

EMBO molecular medicine, 2018-09, Vol.10 (9), p.n/a

2018

Link zum Volltext

Verfügbarkeit prüfen

Consistency and reproducibility of next‐generation sequencing in cytopathology: A second worldwide ring trial study on improved cytological molecular reference specimens

Cancer cytopathology, 2019-05, Vol.127 (5), p.285-296

2019

Link zum Volltext

Verfügbarkeit prüfen

Fibroblast growth factor receptor 1 gene amplification in pancreatic ductal adenocarcinoma

Histopathology, 2013-08, Vol.63 (2), p.157-166

2013

Link zum Volltext

Verfügbarkeit prüfen

Implementing TMB measurement in clinical practice: considerations on assay requirements

ESMO open, 2019-01, Vol.4 (1), p.e000442-e000442, Article e000442

2019

Link zum Volltext

Verfügbarkeit prüfen

Biomarkers for Homologous Recombination Deficiency in Cancer

Journal of personalized medicine, 2021-06, Vol.11 (7), p.612

2021

Link zum Volltext

Verfügbarkeit prüfen

Overview of Molecular Detection Technologies for MET in Lung Cancer

Cancers, 2023-05, Vol.15 (11), p.2932

2023

Link zum Volltext

Verfügbarkeit prüfen

MET amplification status in therapy-naïve adeno- and squamous cell carcinomas of the lung

Clinical cancer research, 2015-02, Vol.21 (4), p.907-915

2015

Link zum Volltext

Verfügbarkeit prüfen

Comparison of Blood Collection Tubes from Three Different Manufacturers for the Collection of Cell-Free DNA for Liquid Biopsy Mutation Testing

The Journal of molecular diagnostics : JMD, 2017-09, Vol.19 (5), p.801-804

2017

Link zum Volltext

Verfügbarkeit prüfen

β-Catenin (CTNNB1) mutations and clinicopathological features of mesenteric desmoid-type fibromatosis

Histopathology, 2013-01, Vol.62 (2), p.294-304

2013

Link zum Volltext

Verfügbarkeit prüfen

Detection of gene fusions using targeted next-generation sequencing: a comparative evaluation

BMC medical genomics, 2021-02, Vol.14 (1), p.62-62, Article 62

2021

Link zum Volltext

Verfügbarkeit prüfen

Clinicopathological and molecular features of a large cohort of gastrointestinal stromal tumors (GISTs) and review of the literature: BRAF mutations in KIT/PDGFRA wild-type GISTs are rare events

Human pathology, 2017-04, Vol.62, p.206-214

2017

Link zum Volltext

Verfügbarkeit prüfen

Genetic Heterogeneity of MET-Aberrant NSCLC and Its Impact on the Outcome of Immunotherapy

Journal of thoracic oncology, 2021-04, Vol.16 (4), p.572-582

2021

Link zum Volltext

Verfügbarkeit prüfen

Immune profile and immunosurveillance in treatment-naive and neoadjuvantly treated esophageal adenocarcinoma

Cancer Immunology, Immunotherapy, 2020-04, Vol.69 (4), p.523-533

2020

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 229

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(211)
Mit Volltextzugriff
(220)

Publikationsform

Sprache

Englisch
(218)
Japanisch
(38)
Deutsch
(12)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

Clinical and Pathological Characteristics of KEAP1 - and NFE2L2 -Mutated Non-Small Cell Lung Carcinoma (NSCLC)

NOTCH, ASCL1, p53 and RB alterations define an alternative pathway driving neuroendocrine and small cell lung carcinomas

Testing NTRK testing: Wet‐lab and in silico comparison of RNA‐based targeted sequencing assays

NTRK testing: First results of the QuiP‐EQA scheme and a comprehensive map of NTRK fusion variants and their diagnostic coverage by targeted RNA‐based NGS assays

Predictive molecular pathology of lung cancer in Germany with focus on gene fusion testing: Methods and quality assurance

Analysis of tumor mutational burden: correlation of five large gene panels with whole exome sequencing

Genetic instability and recurrent MYC amplification in ALK‐translocated NSCLC: a central role of TP53 mutations

Managing Difficulties of Microsatellite Instability Testing in Endometrial Cancer-Limitations and Advantages of Four Different PCR-Based Approaches

Prevalence and potential biological role of TERT amplifications in ALK translocated adenocarcinoma of the lung

NGS-based BRCA1/2 mutation testing of high-grade serous ovarian cancer tissue: results and conclusions of the first international round robin trial

Comparative proteomics reveals a diagnostic signature for pulmonary head‐and‐neck cancer metastasis

Consistency and reproducibility of next‐generation sequencing in cytopathology: A second worldwide ring trial study on improved cytological molecular reference specimens

Fibroblast growth factor receptor 1 gene amplification in pancreatic ductal adenocarcinoma

Implementing TMB measurement in clinical practice: considerations on assay requirements

Biomarkers for Homologous Recombination Deficiency in Cancer

Overview of Molecular Detection Technologies for MET in Lung Cancer

Harmonization and Standardization of Panel-Based Tumor Mutational Burden Measurement: Real-World Results and Recommendations of the Quality in Pathology Study

MET amplification status in therapy-naïve adeno- and squamous cell carcinomas of the lung

Comparison of Blood Collection Tubes from Three Different Manufacturers for the Collection of Cell-Free DNA for Liquid Biopsy Mutation Testing

β-Catenin (CTNNB1) mutations and clinicopathological features of mesenteric desmoid-type fibromatosis

Detection of gene fusions using targeted next-generation sequencing: a comparative evaluation

Clinicopathological and molecular features of a large cohort of gastrointestinal stromal tumors (GISTs) and review of the literature: BRAF mutations in KIT/PDGFRA wild-type GISTs are rare events

Genetic Heterogeneity of MET-Aberrant NSCLC and Its Impact on the Outcome of Immunotherapy

Immune profile and immunosurveillance in treatment-naive and neoadjuvantly treated esophageal adenocarcinoma

Activating ERBB2/HER2 mutations indicate susceptibility to pan-HER inhibitors in Lynch and Lynch-like colorectal cancer

Suchergebnisse filtern